Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

TIMOTHY JAYASUNDERA

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1811908205
CMS profile
354861
Location
NEW YORK, NY

General Payments · PY2018–2024

$101,636.46

  • Reported across 308 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,361.78

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $15,046.62 44
PY2019 $7,033.94 52
PY2020 $16,286.64 48
PY2021 $36,505.16 72
PY2022 $15,345.05 43
PY2023 $9,057.27 35
PY2024 $2,361.78 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Actelion Pharmaceuticals US, Inc. $30.15 01/29/2024 Food and Beverage Undisputed 01/23/2026 1078904265 CMS
Actelion Pharmaceuticals US, Inc. $33.49 05/17/2024 Food and Beverage Undisputed 01/23/2026 1078904525 CMS
Amgen Inc. $22.09 01/30/2024 Food and Beverage Undisputed 01/23/2026 1115763956 CMS
AstraZeneca Pharmaceuticals LP $25.73 01/17/2024 Food and Beverage Undisputed 01/23/2026 1104658459 CMS
AstraZeneca Pharmaceuticals LP $125.00 01/23/2024 Food and Beverage Undisputed 01/23/2026 1105440221 CMS
AstraZeneca Pharmaceuticals LP $24.01 02/07/2024 Food and Beverage Undisputed 01/23/2026 1105645452 CMS
AstraZeneca Pharmaceuticals LP $19.08 02/21/2024 Food and Beverage Undisputed 01/23/2026 1105719592 CMS
AstraZeneca Pharmaceuticals LP $125.00 07/17/2024 Food and Beverage Undisputed 01/23/2026 1104241361 CMS
AstraZeneca Pharmaceuticals LP $1,850.00 07/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105454187 CMS
AstraZeneca Pharmaceuticals LP $15.14 07/24/2024 Food and Beverage Undisputed 01/23/2026 1105353117 CMS
Boston Scientific Corporation $24.62 11/26/2024 Food and Beverage Undisputed 01/23/2026 1092267940 CMS
Boston Scientific Corporation $22.92 12/21/2024 Food and Beverage Undisputed 01/23/2026 1092267938 CMS
Janssen Pharmaceuticals, Inc $21.67 04/04/2024 Food and Beverage Undisputed 01/23/2026 1078113726 CMS
SHIELD THERAPEUTICS INC $22.88 12/06/2024 Food and Beverage Undisputed 01/23/2026 1150156698 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.